Image

Empowering Latinas to Obtain Guideline Concordant Screenings

Empowering Latinas to Obtain Guideline Concordant Screenings

Recruiting
50-74 years
Female
Phase N/A

Powered by AI

Overview

The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat Brease Cancer (BC) screening.

Description

To further test the added benefits of the empower approach relative to traditional educate approaches. Past community research among Latinas has primarily focused on one-time BC screening among intervention participants. The design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat BC screening. The investigator will estimate the widespread effects of interventions by prospectively collecting data from network members not involved in the RCT. The investigator will also explore "active ingredients" that underlie intervention effects, including psychosocial, IS and network mechanisms. Overall, the investigator will demonstrate whether and how non-adherent Latinas may "boost" intervention effects throughout their networks.

The investigator's goal is to further test the added benefits of the empower approach relative to traditional educate approaches. Past community research among Latinas has primarily focused on one-time BC screening among intervention participants. The investigator's novel design builds on past studies by integrating social network analysis (SNA) and implementation science (IS) into a longitudinal randomized clinical trial (RCT). The investigator will compare the long-term effects of interventions by examining guideline-concordant initial and repeat BC screening. The investigator will estimate the widespread effects of interventions by prospectively collecting data from network members not involved in the RCT. The investigator will also explore "active ingredients" that underlie intervention effects, including psychosocial, IS and network mechanisms. Overall, the investigator will demonstrate whether and how non-adherent Latinas may "boost" intervention effects throughout their networks.

Aim 1: Among 400 non-adherent Latinas, the investigator will compare intervention effects on BC screening, using an individual RCT in a federally qualified health center (FQHC). The investigator will use the US Preventative Services Task Force (USPSTF) guidelines - i.e., 50-74 year-olds should obtain mammograms every 2 years.

Aim 2: Among 200 network members of non-adherent Latinas, the investigator will compare intervention effects on BC screening, based on the USPSTF guidelines.

Aim 3: The investigator will explore mechanisms of change underlying intervention effects on BC screening using IS measures, descriptive SNA, and structural equation models. If study arms are comparable, the investigator will examine which mechanisms may predict multilevel intervention effects across approaches.

Eligibility

Inclusion Criteria:

        Aim 1. (1) female biological sex; (2) identification as Latinas; (3) non-adherence to
        USPSTF guidelines (52-74 years old, no mammogram in past 2 years, no previous BC
        diagnosis); (4) no previous history of health volunteerism; and (5) not a network member
        enrolled in Aim 2.
        Aim 2. (1) female biological sex; (2) eligibility to obtain BC screenings by USPSTF
        guidelines (i.e., 50-74 years old, no personal BC history); (3) referral from non-adherent
        Latinas; (4) no previous history of health volunteerism; and (5) no participation in the
        RCT (not an Aim 1 participant, no Session #3 attendance).
        Exclusion Criteria:
        Aim 1: (1) Not meeting at least one of the aforementioned Aim 1 inclusion criteria.
        Aim 2: (1) Not meeting at least one of the aforementioned Aim 1 inclusion criteria.

Study details
    Breast Cancer Screening

NCT05841355

University of Illinois at Chicago

26 January 2024

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.